News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The NIH awarded more than $8.3 million to study 1,000 pregnant individuals with heart conditions in an effort to combat maternal mortality and morbidity.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.

Dr. Rebecca Lobell shares what causes infertility and when a person should talk to their doctor about issues conceiving.

KCTV talked to Dr. Rebecca Lobell about infertility and the steps a woman can take when she is trying to conceive.

Saint Luke’s has been delivering babies for 135 years. To honor this anniversary, we are taking a look back at Kansas City through the decades.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

This year, Michelle almost skipped her preventive screening, but instead of skipping, she chose to get her first 3D mammogram. And like many women, she wasn’t aware that it was now covered by insurance.